ArticleBMC medical imaging2026

Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer.

Emir Gokhan Kahraman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.